Evoke Wealth’s iShares S&P GSCI Commodity-Indexed Trust GSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,660
Closed -$217K 198
2023
Q3
$217K Sell
9,660
-1,050
-10% -$22.6K 0.01% 342
2023
Q2
$209K Hold
10,710
0.01% 334
2023
Q1
$215K Hold
10,710
0.01% 320
2022
Q4
$227K Hold
10,710
0.01% 323
2022
Q3
$220K Sell
10,710
-143,740
-93% -$3.16M 0.01% 300
2022
Q2
$3.57M Sell
154,450
-50,720
-25% -$1.23M 0.13% 82
2022
Q1
$4.65M Buy
205,170
+3,030
+1% +$62.4K 0.15% 75
2021
Q4
$3.46M Buy
202,140
+36,911
+22% +$637K 0.11% 96
2021
Q3
$2.79M Sell
165,229
-1
-0% -$16 0.1% 101
2021
Q2
$2.66M Buy
165,230
+5,510
+3% +$83.9K 0.1% 109
2021
Q1
$2.23M Buy
159,720
+156,801
+5,372% +$2.15M 0.1% 107
2020
Q4
$36K Hold
2,919
﹤0.01% 408
2020
Q3
$31K Hold
2,919
﹤0.01% 422
2020
Q2
$30K Sell
2,919
-1
-0% -$10 ﹤0.01% 413
2020
Q1
$27.2K Hold
2,920
﹤0.01% 397
2019
Q4
$47.3K Buy
2,920
+1
+0% +$16 0.01% 425
2019
Q3
$43.9K Buy
+2,919
New +$44.5K 0.01% 496

Other funds holding GSG

Evoke Wealth's GSG Position: Q4 2023 in Review

Evoke Wealth sold out of iShares S&P GSCI Commodity-Indexed Trust (GSG) in Q4 2023, closing a stake of 9,660 shares — an estimated $217K sold.

Evoke Wealth first reported a position in GSG in Q3 2019 and held it in 17 quarters. The position peaked at $4.65M in Q1 2022. 138 funds tracked by Wall St. Rank hold GSG as of Q4 2023.

  • Evoke Wealth reported no remaining iShares S&P GSCI Commodity-Indexed Trust position as of Q4 2023 after selling out during the quarter.
  • Evoke Wealth sold 9,660 iShares S&P GSCI Commodity-Indexed Trust shares in Q4 2023, an estimated $217K.
  • Evoke Wealth first reported a position in iShares S&P GSCI Commodity-Indexed Trust in Q3 2019 and held it in 17 quarters.
  • Evoke Wealth's iShares S&P GSCI Commodity-Indexed Trust position peaked at $4.65M in Q1 2022.
  • 138 funds tracked by Wall St. Rank held iShares S&P GSCI Commodity-Indexed Trust as of Q4 2023.

Based on Evoke Wealth's 13F filing for Q4 2023, filed 12 Feb 2024.